Vor Biopharma (VOR) Other Accumulated Expenses (2020 - 2026)

Vor Biopharma (VOR) has reported Other Accumulated Expenses for 7 consecutive years, with $188000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 327.27% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $188000.0 (up 327.27% YoY), while the FY2025 annual figure was $554000.0, down 36.47% from the prior year.
• Other Accumulated Expenses eased to $188000.0 in Q1 2026 per VOR's latest filing, from $554000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.4 million in Q3 2023 and bottomed at $35000.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $410941.2 across 5 years, with a median of $219000.0 in 2024.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses sank 91.21% — and 2024, when it soared 1644.0%.
• Vor Biopharma's Other Accumulated Expenses stood at $569000.0 in 2022, then tumbled by 91.21% to $50000.0 in 2023, then jumped by 1644.0% to $872000.0 in 2024, then sank by 36.47% to $554000.0 in 2025, then slumped by 66.06% to $188000.0 in 2026.
• Business Quant data shows VOR's Other Accumulated Expenses at $188000.0 in Q1 2026, $554000.0 in Q4 2025, and $35000.0 in Q3 2025.